Key facts
- This page summarizes Nancy Duitch's Form 4 filing for Cure Pharmaceutical Holding Corp. (AVRW).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 May 2021, 20:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.6950 to $0.7000. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 2 decimal points.